Healthcare -
Biotechnology - NASDAQ - US
$ 1.985
5.59 %
$ 561 M
Market Cap
-2.51
P/E
ERAS - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ERAS - Erasca, Inc.
1.3 M
LAST VALUE
-94.57%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR